This bill, titled the HIV Medication Access Act, aims to strengthen and clarify U.S. foreign assistance efforts to combat HIV/AIDS by amending the Foreign Assistance Act of 1961. It explicitly designates various forms of HIV/AIDS assistance, including efforts to reduce infection risk and treatment activities, as core life-saving humanitarian assistance . A key provision adds pre-exposure prophylaxis (PrEP) medications to the list of specific assistance activities. Furthermore, the bill expands the focus on "specific populations" to include at-risk populations identified through scientific analysis designated by the World Health Organization. These changes underscore a commitment to comprehensive and evidence-based approaches in global HIV/AIDS prevention and treatment.